The Independent Payment Advisory Board was supposed to make it easier for Congress to control Medicare spending. But Congress never loved it. Now it's gone.
Mr. Azar, a former drug company executive, immediately confronts two huge challenges: how to rein in drug prices and how to administer the Affordable Care Act.
A lot of people could do with a little more health and financial literacy, not just Medicaid recipients. But linking it to retaining medical eligibility may not make sense.